HORN HOWARD (Chief Financial Officer) sold 4.6% of their position (4.70K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $117.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/4/2026ACC: 0001193125-26-332536
Officer· Chief Financial Officer
Since Mar 2026
-4.70K
Net shares
Net seller
$117.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.70K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.70K
Price / share
$24.92
Trade value
$117.02K
% of position
4.6%
8/3/2026
100.99K→96.30K
Total
Net shares
−4.70K
Net value
-$117.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | S · Sale | −4.70K | $24.92 | $117.02K | 4.6% | 100.99K | 96.30K |
| Total | −4.70K | -$117.02K | ||||||
Derivative Transactions0
No derivative transactions reported